Contact Us
  Search
The Business Research Company Logo
AI In Medical Devices Global Market Opportunities And Strategies To 2035
Published :July 2026
Pages :378
Format :PDF
Delivery Time :2-3 Business Days
Why 2-3 days? We update the report with the latest data and news before delivery. Let us know if you need us to expedite.
Report Price :$4,490.00

AI In Medical Devices Global Market Opportunities And Strategies To 2035

By Offerings (Hardware, Software, Services), By Technology (Context Awareness, Deep learning, Machine learning, Natural Language Processing, Predictive Analytics, Other Technologies), By Deployment (Cloud, On-Premises), By Application (Patient Care, Treatment, Diagnosis And Monitoring, Other Applications), By End-User (Hospitals And Healthcare Providers, Homecare Settings, Pharmaceutical And Biotechnology Companies, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2035

AI In Medical Devices Market Definition

Artificial intelligence (AI) in medical devices refers to the integration of artificial intelligence technologies such as machine learning, deep learning, natural language processing, predictive analytics and context-aware computing into medical devices and healthcare systems to assist in diagnosis, monitoring, treatment planning, patient management and clinical decision-making. AI-enabled medical devices are designed to analyze large volumes of medical and patient-related data, identify patterns, automate workflows and support healthcare professionals in delivering accurate and efficient care. The AI in medical devices market consists of sales of AI in medical devices by entities (organizations, sole traders and partnerships) through the development, production and sale of AI-integrated medical devices, AI-based healthcare software platforms and associated implementation and maintenance services. These devices and solutions are used by hospitals, healthcare providers, patients, pharmaceutical and biotechnology companies, healthcare payers and research institutions to improve operational efficiency, enhance patient outcomes, support early disease detection and optimize treatment procedures.
AI In Medical Devices Global Market Opportunities And Strategies To 2035 Market Size and growth rate 2026 to 2030: Graph

AI In Medical Devices Market Size

The global AI in medical devices market reached a value of nearly $12,389.1 million in 2025, having grown at a compound annual growth rate (CAGR) of 29.5% since 2020. The market is expected to grow from $12,389.1 million in 2025 to $40,022.9 million in 2030 at a rate of 26.4%. The market is then expected to grow at a CAGR of 24.3% from 2030 and reach $118,802.8 million in 2035. Growth in the historic period resulted from favorable government initiatives towards AI-enabled medical devices, rising adoption of healthcare cloud-based AI platforms, rising adoption of wearable medical devices and efforts towards early disease detection solutions. Factors that negatively affected growth in the historic period were concerns regarding data privacy and cybersecurity and high cost of AI medical devices. Going forward, demand for improved diagnostic accuracy, increasing digital transformation in healthcare, growing demand for remote patient monitoring solutions and growing adoption of electronic health records (EHRs) will drive the growth. Factors that could hinder the growth of the AI in medical devices market in the future include stringent regulatory approval processes for medical devices, limited availability of skilled AI and healthcare professionals and impact of trade wars and tariffs.
Research Expert

Book your 30 minutes free consultation with our research experts

AI In Medical Devices Market Segmentation

The AI in medical devices market is segmented by offerings, by technology, by deployment, by application and by end-user.

By Offerings –
The AI in medical devices market is segmented by offerings into:
    • a) Hardware
    • b) Software
    • c) Services
The software market was the largest segment of the AI in medical devices market segmented by offerings, accounting for 51.3% or $6,350.7 million of the total in 2025. Going forward, the software segment is expected to be the fastest-growing segment in the AI in medical devices market segmented by offerings, at a CAGR of 30.9% during 2025-2030.

By Technology –
The AI in medical devices market is segmented by technology into:
    • a) Context Awareness
    • b) Deep Learning
    • c) Machine Learning
    • d) Natural Language Processing
    • e) Predictive Analytics
    • f) Other Technologies
The machine learning market was the largest segment of the AI in medical devices market segmented by technology, accounting for 34.5% or $4,268.7 million of the total in 2025. Going forward, the deep learning segment is expected to be the fastest-growing segment in the AI in medical devices market segmented by technology, at a CAGR of 32.7% during 2025-2030.

By Deployment –
The AI in medical devices market is segmented by deployment into:
    • a) Cloud
    • b) On-Premises
The cloud market was the largest segment of the AI in medical devices market segmented by deployment, accounting for 66.4% or $8,221.2 million of the total in 2025. Going forward, the cloud segment is expected to be the fastest-growing segment in the AI in medical devices market segmented by deployment, at a CAGR of 27.2% during 2025-2030.

By Application –
The AI in medical devices market is segmented by application into:
    • a) Patient Care
    • b) Treatment
    • c) Diagnosis And Monitoring
    • d) Other Applications
The diagnosis and monitoring market was the largest segment of the AI in medical devices market segmented by application, accounting for 41.8% or $5,177.5 million of the total in 2025. Going forward, the diagnosis and monitoring segment is expected to be the fastest-growing segment in the AI in medical devices market segmented by application, at a CAGR of 30.5% during 2025-2030.

By End-User –
The AI in medical devices market is segmented by end-user into:
    • a) Hospitals And Healthcare Providers
    • b) Homecare Settings
    • c) Pharmaceutical And Biotechnology Companies
    • d) Other End Users
The hospitals and healthcare providers market was the largest segment of the AI in medical devices market segmented by end-user, accounting for 67.9% or $8,407.9 million of the total in 2025. Going forward, the hospitals and healthcare providers segment is expected to be the fastest-growing segment in the AI in medical devices market segmented by end-user, at a CAGR of 27.4% during 2025-2030.

By Geography - The AI in medical devices market is segmented by geography into:
      o Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • Indonesia
      • South Korea
      o North America
      • USA
      • Canada
      o South America
      • Brazil
      o Western Europe
      • France
      • Germany
      • UK
      • Italy
      • Spain
      o Eastern Europe
      • Russia
      o Middle East
      o Africa
North America was the largest region in the AI in medical devices market, accounting for 40.4% or $5,003.8 million of the total in 2025. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the AI in medical devices market will be Asia-Pacific and Middle East where growth will be at CAGRs of 30.3% and 26.8% respectively. These will be followed by Africa and South America where the markets are expected to grow at CAGRs of 26.4% and 25.8% respectively.

AI In Medical Devices Market Drivers

The key drivers of the AI in medical devices market include: Demand For Improved Diagnostic Accuracy During the forecast period, increasing demand for improved diagnostic accuracy is expected to propel growth in the AI in medical devices market. As rising patient volumes, growing prevalence of chronic diseases and increasing complexity of clinical decision-making continue to place pressure on healthcare systems, healthcare providers are expected to experience greater demand for technologies capable of supporting faster, more precise and data-driven diagnostic assessments. Increasing focus on reducing diagnostic errors and the need for enhanced clinical efficiency are expected to drive demand for AI in medical devices equipped with machine learning algorithms, predictive analytics, automated image interpretation and real-time clinical decision support technologies. The demand for improved diagnostic accuracy growth contribution during the forecast period in 2026 is 2.5%.

AI In Medical Devices Market Restraints

The key restraints on the AI in medical devices market include: Stringent Regulatory Approval Processes For Medical Devices During the forecast period, stringent regulatory approval processes for medical devices are expected to restrict the growth of the AI in medical devices market. Increasing regulatory requirements related to device safety, clinical validation, software reliability, cybersecurity compliance and risk assessment, combined with evolving standards for AI-enabled healthcare technologies are expected to create challenges for the development and commercialization of advanced medical devices. From a regulatory and operational perspective, extensive approval procedures, documentation requirements and clinical testing processes may make it difficult for medical device manufacturers to efficiently launch, scale and update AI-powered healthcare solutions across different healthcare markets. Growth affected by the stringent regulatory approval processes for medical devices during the forecast period in 2026 is -2.0%.

AI In Medical Devices Market Competitive Landscape

Major Competitors are:

  • Medtronic Plc
  • GE HealthCare Technologies Inc.
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • NVIDIA Corporation
  • Other Competitors Include:

  • Intuitive Surgical Inc.
  • Stryker Corporation
  • Canon Inc.
  • Zimmer Biomet Holdings Inc.
  • Intel Corporation
  • Trivitron Healthcare
  • S10 Health Solutions
  • Predible Health
  • Artelus
  • Cochlear Limited
  • Canon Medical Systems Corporation
  • Mindray Medical International Limited
  • United Imaging Healthcare Co., Ltd.
  • Wandong Medical Co., Ltd.
  • Yizumi Group
  • Shinva Medical Instrument Co., Ltd.
  • Wellesta Holdings
  • CloudMedx
  • Qure.ai
  • Trivitron Healthcare
  • Canon Medical Systems Corporation
  • Philips
  • GE HealthCare
  • Roche
  • Sectra
  • Canon Medical Systems
  • Aidoc
  • Butterfly Network
  • IBM
  • Canon Medical Systems
  • General Electric Company
  • Pathcore
  • Synaptive Medical
  • Cloud DX
  • BenchSci
  • Thornhill Medical
  • Google Health
  • International Business Machines Corporation
  • PathAI Inc.
  • Arterys Inc.
  • Intel Corporation
  • Brainomix Ltd.
  • Need data on a specific region in this market?

    Opportunities And Recommendations In The AI In Medical Devices Market

    Opportunities – The top opportunities in the AI in medical devices market segmented by offerings will arise in the software segment, which will gain $18,013.2 million of global annual sales by 2030. The top opportunities in the AI in medical devices market segmented by technology will arise in the machine learning segment, which will gain $10,278.6 million of global annual sales by 2030. The top opportunities in the AI in medical devices market segmented by deployment will arise in the cloud segment, which will gain $19,131.3 million of global annual sales by 2030. The top opportunities in the AI in medical devices market segmented by application will arise in the diagnosis and monitoring segment, which will gain $14,408.4 million of global annual sales by 2030. The top opportunities in the AI in medical devices market segmented by end-user will arise in the hospitals and healthcare providers segment, which will gain $19,856.3 million of global annual sales by 2030. The AI in medical devices market size will gain the most in the USA at $8,629.3 million. Recommendations- To take advantage of the opportunities, The Business Research Company recommends the AI in medical devices companies to focus on AI enabled dialysis ecosystems for connected renal care expansion, focus on AI driven hemodynamic monitoring for predictive clinical decision support, focus on AI enabled point of care ultrasound for rapid diagnostic expansion, focus on AI enabled CT imaging systems for high precision diagnostic advancement, focus on ai medical device software platforms for scalable healthcare intelligence, focus on deep learning driven AI platforms in medical devices, focus on AI-enabled diagnosis and monitoring systems for scalable clinical impact, focus on value-based and tiered pricing models for AI medical devices, focus on clinical evidence led promotion and hospital decision maker targeting, focus on digital clinical ecosystems and multi channel medical education campaigns, focus on AI integration across hospitals and healthcare provider ecosystems.
    Chat with us